4dmedical Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure ventilation and perfusion; and Contrast Free Pulmonary Angiography (CFPA) products, as well as small animal ventilators and preclinical scanners. 4Dmedical Limited partners with the University of Miami Health System to establish the functional lung imaging research program. The company was incorporated in 2012 and is headquartered in Melbourne, Australia.
|Primary activities||Medical imaging software and hardware provider|
|Industry / Sector||Medical Devices / Healthcare|
|Full time employees||95|
|Mailing address||468 St Kilda Road Suite 501 Level 5 Melbourne VIC 3004 Australia|
|Phone / Fax||61 3 9545 5940 /|
|Share registry||LINK MARKET SERVICES LIMITED|
4dmedical does not pay dividends.
As of Dec 2021, following are the company executives and directors listed on 4dmedical.
|Dr. Andreas Fouras M.A.I.C.D., Ph.D.||Founder, MD, CTO, CEO & Exec. Director||597.76k|
|Mr. Heath Lee C.A.||Chief Financial Officer||185.05k|
|Mr. Craige Pendleton-Browne B.Sc., M.B.A.||Chief Information Officer|
|Mr. Paul Cooke||Sr. VP of Sales & Marketing|
|Dr. Aidan Jamison B.E., Ph.D.||Sr. VP of Engineering|
|Dr. Michael Curtis||Chief Software Architect|
|Ms. Charlene Stahr||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of 4dmedical is 403.45M and its enterprise value is 324.26M. The enterprise value to revenue ratio of 4DX is 1.49k.
Companies similar to 4dmedical (4DX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
4dmedical (ASX:4DX) Frequently Asked Questions
1. What is 4dmedical's Stock Symbol?
4dmedical trades on ASX under the ticker symbol "4DX".
2. What is 4dmedical's stock price today?
One share of 4DX stock can currently be purchased for approximately $1.31.
3. How can I contact 4dmedical?
4dmedical's mailing address is 468 St Kilda Road Suite 501 Level 5 Melbourne VIC 3004 Australia. The company can be reached via phone at 61 3 9545 5940.
4. What is 4dmedical's official website?
The official website of 4dmedical is http://www.4dmedical.com.
5. Which share registry manages 4dmedical's stock?
4dmedical's stock is managed by LINK MARKET SERVICES LIMITED.